Clonaid Corp Remains A Mystery
By Frances Kerry

FORT LAUDERDALE, Fla. (Reuters) - Clonaid, the company that says it produced two cloned human babies but has given no evidence, said on Saturday it raises money for its project but declined to give details of the company's legal status, financial position or where it is based.
Clonaid was founded by the Raelian sect that believes humans were originally created by aliens who mastered cloning. Leading scientists believe the company's claim in the last two weeks to have successfully cloned humans is a hoax.
At a news conference, Clonaid vice president Thomas Kaenzig was as elusive about the company's structure as Clonaid has been about giving proof of its alleged scientific breakthrough, which has also alarmed religious leaders and ethics experts.
Kaenzig, facing a barrage of questions before speaking at an investment conference, urged the journalists to report facts, but provided almost none.
Kaenzig declined to say where the company is based, where any of its physical premises are, what its legal status is, or to give any indication of its finances, other than that it was not registered in the United States. He also said a Clonaid legal entity, Valiant Venture, was registered several years ago in the Bahamas but that government canceled the registration.
"We do have different legal entities, different companies, not in the United States," he said. "I don't want to go into details of what kind of legal entity we're talking about."
He said Clonaid had received e-mailed death threats after the first announcement of a cloned baby, but gave no details.
Clonaid announced on Dec. 27 at a South Florida hotel that it had produced the world's first cloned baby, called Eve and born on Dec. 26 to an American mother. Last week, it said a second cloned baby was born on Jan. 3 to a Dutch woman.
The company has said in recent days it delayed DNA testing that could prove the cloning because the parents want their privacy and have legal concerns. On Monday, the independent scientist and journalist brought in by Clonaid to verify the cloning of a human denounced their claim as a possible hoax.
Clonaid was invited to speak at the conference on cloning in general as an investment possibility, said Marilyn Clark, a vice president for sponsor Royal Expo Money, but added that it could not solicit investment.
Kaenzig said shares were sold -- although he did not say of what company -- usually with a minimum value of $25,000, to investors, and potential investors could contact the company for more information through e-mail. The company also lists a Las Vegas phone number to request information.
He said the parents of the first cloned babies had not paid for the service but eventually Clonaid would charge $100,000 to $200,000 for the procedure.
Your Comments Are Always Welcome At
Send Comment



This Site Served by TheHostPros